Sign up
Quantellect · Congress · Trade Detail
NYSE: DGXQuest Diagnostics Incorporated
DemocratHouse

Kathy E. Manning sold Quest Diagnostics Incorporated (NYSE: DGX)

Kathy E. Manning (D-NC), a U.S. Representative, has disclosed 2 trades in Quest Diagnostics Incorporated (DGX) since 2022, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Kathy E. Manning sold $1,001 - $15,000 of Quest Diagnostics Incorporated (NYSE: DGX) on August 3, 2022. Since that trade, DGX is up +83.04% against the S&P 500 up +88.31%, an outperformance of -5.27%.

Across these filings, Kathy E. Manning has been a balanced trader of DGX (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

DGX trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2022

Kathy E. Manning's DGX trades vs the price

DGX is up +83.04% since Kathy E. Manning sold on August 3, 2022, versus +88.31% for the S&P 500.

Performance since this trade

Price change since trade
+83.04%
S&P 500 change since trade
+88.31%
Outperformance vs S&P 500
-5.27%

All Kathy E. Manning DGX trades

TradedTypeSizeReturnEst. profit
August 3, 2022SELL$128.01+83.04%
July 20, 2022BUY$125.14+87.23%+$6K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Kathy E. Manning & DGX trading FAQ

Is it legal for Kathy E. Manning to trade Quest Diagnostics Incorporated (DGX) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Quest Diagnostics Incorporated (DGX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Kathy E. Manning sell DGX?

Kathy E. Manning disclosed a sale of $1,001 - $15,000 of Quest Diagnostics Incorporated (DGX) on August 3, 2022, according to public STOCK Act filings.

How has DGX performed since Kathy E. Manning's trade?

Since Kathy E. Manning sold DGX on August 3, 2022, the stock is up +83.04%, versus +88.31% for the S&P 500 over the same period, an outperformance of -5.27%.

How many times has Kathy E. Manning traded DGX?

Kathy E. Manning has disclosed 2 DGX trades since 2022 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional DGX trades?

Quantellect tracks every disclosed congressional trade in Quest Diagnostics Incorporated (DGX) on the Quest Diagnostics Incorporated congressional trading page, which aggregates filings across all members of Congress.

Kathy E. Manning's DGX tradesAll congressional filings for Quest Diagnostics IncorporatedKathy E. Manning's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.